logo
Troilus Gold Corp.'s (TSE:TLG) largest shareholders are individual investors with 59% ownership, institutions own 23%

Troilus Gold Corp.'s (TSE:TLG) largest shareholders are individual investors with 59% ownership, institutions own 23%

Yahoo04-04-2025
Significant control over Troilus Gold by individual investors implies that the general public has more power to influence management and governance-related decisions
A total of 25 investors have a majority stake in the company with 40% ownership
Insiders have bought recently
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
A look at the shareholders of Troilus Gold Corp. (TSE:TLG) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual investors with 59% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
And institutions on the other hand have a 23% ownership in the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies.
Let's delve deeper into each type of owner of Troilus Gold, beginning with the chart below.
See our latest analysis for Troilus Gold
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
Troilus Gold already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Troilus Gold's historic earnings and revenue below, but keep in mind there's always more to the story.
It looks like hedge funds own 14% of Troilus Gold shares. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Equinox Partners Investment Management LLC is currently the largest shareholder, with 14% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 9.5% and 2.8%, of the shares outstanding, respectively. Additionally, the company's CEO C. Reid directly holds 1.4% of the total shares outstanding.
Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Shareholders would probably be interested to learn that insiders own shares in Troilus Gold Corp.. It has a market capitalization of just CA$167m, and insiders have CA$6.8m worth of shares, in their own names. It is good to see some investment by insiders, but we usually like to see higher insider holdings. It might be worth checking if those insiders have been buying.
The general public, who are usually individual investors, hold a substantial 59% stake in Troilus Gold, suggesting it is a fairly popular stock. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 2 warning signs we've spotted with Troilus Gold .
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future .
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What Canadian National Railway (TSX:CNR)'s Reduced Earnings Guidance Means For Shareholders
What Canadian National Railway (TSX:CNR)'s Reduced Earnings Guidance Means For Shareholders

Yahoo

time24 minutes ago

  • Yahoo

What Canadian National Railway (TSX:CNR)'s Reduced Earnings Guidance Means For Shareholders

Earlier this month, Canadian National Railway faced ongoing operational challenges and reported that its expected business turnaround had not materialized, leading to reduced earnings growth guidance. This setback has sparked negative sentiment, with some industry observers drawing comparisons to competitors viewed as better positioned for growth and highlighting alternatives within the sector. With reduced earnings growth guidance in focus, we'll explore how these operational issues may shift Canadian National Railway's investment narrative. AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Canadian National Railway Investment Narrative Recap To be a shareholder in Canadian National Railway, you need confidence in the company's ability to capitalize on long-term shifts toward intermodal and bulk transport as industries focus on supply chain resilience and North American trade. However, the recent reduction in earnings growth guidance directly impacts the key short-term catalyst, an expected business turnaround, and highlights concerns around volume growth, currently the most prominent risk for the business. The news meaningfully shifts investor attention from network advantages to near-term operational execution. Among recent announcements, the second-quarter results stand out. While CN grew net income and earnings per share compared to the prior year, sales have edged lower, reflecting the ongoing volume and demand pressures underpinning the news event. This reinforces the theme that even targeted capital spending and cost discipline will take time to translate into renewed growth, particularly if market conditions stay challenging. In contrast, investors should also be aware that structural shifts in customer routing and industry competitiveness could... Read the full narrative on Canadian National Railway (it's free!) Canadian National Railway's narrative projects CA$19.6 billion revenue and CA$5.6 billion earnings by 2028. This requires 4.6% yearly revenue growth and a CA$1.0 billion earnings increase from CA$4.6 billion today. Uncover how Canadian National Railway's forecasts yield a CA$153.14 fair value, a 19% upside to its current price. Exploring Other Perspectives Simply Wall St Community members provided 12 fair value estimates for CNR ranging from CA$119.59 to CA$170.64 per share. These divergent opinions come as growth in shipping volumes remains a critical uncertainty for the company's ability to regain momentum, explore the range of forecasts and viewpoints from across the Community. Explore 12 other fair value estimates on Canadian National Railway - why the stock might be worth 7% less than the current price! Build Your Own Canadian National Railway Narrative Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your Canadian National Railway research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision. Our free Canadian National Railway research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Canadian National Railway's overall financial health at a glance. Want Some Alternatives? Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay: Outshine the giants: these 19 early-stage AI stocks could fund your retirement. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 28 companies in the world exploring or producing it. Find the list for free. Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Arvinas, Pfizer's Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment
Arvinas, Pfizer's Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment

Yahoo

timean hour ago

  • Yahoo

Arvinas, Pfizer's Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment

Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc. (NYSE:PFE), announced that the US FDA accepted its New Drug Application/NDA for vepdegestrant. The drug is intended to treat patients with estrogen receptor-positive/ER+, human epidermal growth factor receptor 2-negative/HER2-, ESR1-mutated advanced or metastatic breast cancer who have already received endocrine-based therapy. The FDA has set a Prescription Drug User Fee Act/PDUFA action date of June 5, 2026. The NDA is based on data from the Phase 3 VERITAC-2 clinical trial, which showed a statistically significant and clinically meaningful improvement in median progression-free survival for vepdegestrant compared to fulvestrant. The trial enrolled 624 patients at 213 sites across 25 countries, with 270 of these patients having the ESR1 mutation. A biopharma executive in a meeting room discussing the clinical-stage of a new therapy. The results from this trial were recently presented at the American Society of Clinical Oncology/ASCO 2025 Annual Meeting and published in The New England Journal of Medicine. Vepdegestrant is an investigational oral drug that functions as a PROteolysis TArgeting Chimera/PROTAC estrogen receptor degrader. This marks the first time a PROTAC has demonstrated a clinical benefit in breast cancer patients. Arvinas Inc. (NASDAQ:ARVN) is a clinical-stage biotechnology company that engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally. While we acknowledge the potential of ARVN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Texas Pacific Land Corporation (TPL) Releases Financial and Operating Results for Q2 2025
Texas Pacific Land Corporation (TPL) Releases Financial and Operating Results for Q2 2025

Yahoo

time2 hours ago

  • Yahoo

Texas Pacific Land Corporation (TPL) Releases Financial and Operating Results for Q2 2025

Texas Pacific Land Corporation (NYSE:TPL) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 6, the company released its financial and operating results for Q2 2025, highlighting its financial resilience amid commodity price fluctuations, with quarterly revenue records witnessed in SLEM and produced water royalties. Texas Pacific Land Corporation (NYSE:TPL)'s significant footprint throughout royalties, surface, and water positions it to extract sources of value from the Permian's exceptional resource. A pipeline running through a rural landscape, a reminder of the companies oil and gas Royalty Interest. Texas Pacific Land Corporation (NYSE:TPL)'s total revenues for the 6 months ended June 30, 2025 came in at $383.5 million versus $346.5 million for the 6 months to June 30, 2024. The rise in total revenues was mainly because of a $24.3 million rise in oil and gas royalty revenue, as well as $17.2 million increase in easements and other surface-related income. As of June 30, 2025, Texas Pacific Land Corporation (NYSE:TPL)'s royalty acreage had an estimated 6.0 net well permits, 11.1 net drilled but uncompleted wells, and 5.1 net completed but not producing wells. In particular, record produced water royalty revenue highlights Texas Pacific Land Corporation (NYSE:TPL)'s unique position to provide essential solutions and capture high-quality cash flows. Wedgewood Partners, an investment management company, released its Q4 2024 investor letter. Here is what the fund said: 'Texas Pacific Land Corporation (NYSE:TPL) was a top contributor to performance during both the quarter and the year. Texas Pacific Land continues to be an extraordinarily unique and profitable business. The Company owns over 800,000 surface acres of land in the Texas Permian Basin. The vast majority of this land was acquired in the year 1888 and more recently (i.e. the last 15 years) this land became highly productive oil and gas royalty acreage thanks to modern drilling and completion techniques and technologies. Despite all of these deserved accolades, we liquidated our positions after the stock rallied quite sharply upon being consecutively added to two major stock indexes over the past seven months. The earnings power of the Company has not substantially changed over the past seven months (for better or worse). However, passive indexes and the traders and managers that closely follow and benchmark against those indexes effectively tripled their appraisal of the Company's corporate value, while that value never changed. We will continue to monitor Texas Paci7ic Land from the sidelines and would hope to invest in them again, perhaps after the market's 'animal spirits' subside.' While we acknowledge the potential of TPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store